CD34 + cells in maternal placental blood are mainly fetal in origin and express endothelial markers

Laboratory Investigation

Volumn 89, Issue 8, 2009, Pages 915-923

  Parant, Olivier ^a,b   Dubernard, Gil ^a,b   Challier, Jean Claude ^a,b   Oster, Michèle ^a,b   Uzan, Serge ^a,b   Aractingi, Sélim ^a,b   Khosrotehrani, Kiarash ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

CD34' cells; Endothelial progenitors; FISH; Microchimerism; Placenta

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CYTOKERATIN; STEM CELL FACTOR RECEPTOR; VIMENTIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CD34 SELECTION; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MATERNAL BLOOD; MICROCHIMERISM; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL LINEAGE; CELLS, CULTURED; CHIMERA; CHIMERISM; CHORIONIC VILLI; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; ENDOTHELIUM, VASCULAR; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MATERNAL-FETAL EXCHANGE; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; STEM CELLS; YOUNG ADULT;

EID: 68149148868     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.55     Document Type: Article

References (36)

1. Ariga H, Ohto H, Busch MP, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001;41:1524-1530.
2. Krabchi K, Gros-Louis F, Yan J, et al. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 2001;60:145-150.
3. Holzgreve W, Ghezzi F, Di Naro E, et al. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998;9:669-672.
4. Bianchi DW, Farina A, Weber W, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001;184:703-706.
5. Khosrotehrani K, Johnson KL, Lau J, et al. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003;48:3237-3241.
6. Bianchi DW, Williams JM, Sullivan LM, et al. PCR quantification of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997;61:822-829.
7. Nguyen Huu S, Dubernard G, Aractingi S, et al. Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. Stem Cell Rev 2006;2:111-116.
8. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93:705-708.
9. Khosrotehrani K, Johnson KL, Cha DH, et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004;292:75-80.
10. Srivatsa B, Srivatsa S, Johnson KL, et al. Microchimerism of presumed fetal origin in thyroid specimens from women: a case control study. Lancet 2001;358:2034-2038.
11. Wang Y, Iwatani H, Ito T, et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 2004;325:961-967.
12. Johnson KL, Nelson JL, Furst DE, et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 2001;44:1848-1854.
13. Stevens AM, McDonnell WM, Mullarkey ME, et al. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 2004;84:1603-1609.
14. Tan XW, Liao H, Sun L, et al. Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier? Stem Cells 2005;23:1443-1452.
15. Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 2005;118:1559-1563.
16. O'Donoghue K, Chan J, De La FJ, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004;364:179-182.
17. Osada H, Doi S, Fukushima T, et al. Detection of fetal HPCs in maternal circulation after delivery. Transfusion 2001;41:499-503.
18. Guetta E, Gordon D, Simchen MJ, et al. Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis 2003;30:13-21.
19. Jimenez DF, Leapley AC, Lee CI, et al. Fetal CD34+ cells in the maternal circulation and long-term microchimerism in rhesus monkeys (Macaca mulatta). Transplantation 2005;79:142-146.
20. Adams KM, Lambert NC, Heimfeld S, et al. Male DNA in female donor apheresis and CD34-enriched products. Blood 2003;102:3845-3847.
21. Khosrotehrani K, Leduc M, Bachy V, et al. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol 2008;180:889-897.
22. Nguyen Huu S, Oster M, Uzan S, et al. Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci USA 2007;104:1871-1876.
23. Nguyen Huu S, Oster M, Avril MF, et al. Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol 2009;174:630-637.
24. Gekas C, Dieterlen-Lievre F, Orkin SH, et al. The placenta is a niche for hematopoietic stem cells. Dev Cell 2005;8:365-375.
25. Challier JC, Galtier M, Cortez A, et al. Immunocytological evidence for hematopoiesis in the early human placenta. Placenta 2005;26:282-288.
26. Johnson KL, Zhen DK, Bianchi DW. The use of fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections for the study of microchimerism. Biotechniques 2000;29:1220-1224.
27. Khosrotehrani K, Stroh H, Bianchi DW, et al. Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism. Biotechniques 2003;34:242-244.
28. Khosrotehrani K, Guegan S, Fraitag S, et al. Presence of chimeric maternally derived keratinocytes in cutaneous inflammatory diseases of children: the example of Pityriasis lichenoides. J Invest Dermatol 2006;126:345-348.
29. Godin I, Cumano A. The hare and the tortoise: an embryonic haematopoietic race. Nat Rev Immunol 2002;2:593-604.
30. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997;158:40-47.
31. Khosrotehrani K, Johnson KL, Guegan S, et al. Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol 2005;66:1-12.
32. Vernochet C, Caucheteux SM, Kanellopoulos-Langevin C. Bi-directional cell trafficking between mother and fetus in mouse placenta. Placenta 2007;28:639-649.
33. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353.
34. Gussin HA, Bischoff FZ, Hoffman R, et al. Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Investig 2002;9:357-361.
35. Gussin HA, Sharma AK, Elias S. Culture of endothelial cells isolated from maternal blood using anti-CD105 and CD133. Prenat Diagn 2004;24:189-193.
36. Mikhail MA, M'Hamdi H, Welsh J, et al. High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum Reprod 2008;23:928-933.